PA
FUTU icon

PharVision Advisers’s Futu Holdings FUTU Stock Holding History

PharVision Advisers’s Portfolio FUTU Stock Details FUTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,184
Closed -$359K – 314
2025
Q4 		$359K Buy
2,184
+412
+23% +$70.7K 0.18% 173
2025
Q3 		$308K Buy
+1,772
New +$294K 0.17% 211

Other funds holding FUTU

AMH
Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PharVision Advisers's FUTU Position: Q1 2026 in Review

PharVision Advisers sold out of Futu Holdings (FUTU) in Q1 2026, closing a stake of 2,184 shares — an estimated $359K sold.

PharVision Advisers first reported a position in FUTU in Q3 2025 and held it in 2 quarters. The position peaked at $359K in Q4 2025. 371 funds tracked by Wall St. Rank hold FUTU as of Q1 2026.

  • PharVision Advisers reported no remaining Futu Holdings position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,184 Futu Holdings shares in Q1 2026, an estimated $359K.
  • PharVision Advisers first reported a position in Futu Holdings in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Futu Holdings position peaked at $359K in Q4 2025.
  • 371 funds tracked by Wall St. Rank held Futu Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.